National Collegiate Inventors & Innovators Alliance, INC.
UEI D5S9JZ1KDP49 · MA · SAM.gov record ↗
$13.1M
FY2025 obligations
33
Contract awards
Mar 5, 2021
First action
Sep 25, 2025
Latest action
Obligations by agency
- Department Of Health And Human Services$12.7M
- Department Of Defense$385K
Obligations by NAICS
Monthly obligations
Nov 24
Dec 24
Jan 25
Mar 25
May 25
Jun 25
Jul 25
Aug 25
Sep 25
Contracts ending within 18 months (recompete watch)
| PIID | Description | Agency | NAICS | Obligated | Start | End |
|---|---|---|---|---|---|---|
| 75N92025F00002 ↗ | NIBIB INNOVATION FUNNEL COMMERCIALIZATION CENTER - RADX BLUEPRINT MEDTECH TRANSLATOR COHORT 3 | National Institutes Of Health | 541618 | $5.4M | Aug 29, 2025 | Aug 28, 2026 |
| 75N92023F00001 ↗ | COMMERCIALIZATION CENTER TASK ORDER FOR CANCER SCREENING RESEARCH NETWORK - CONSULTANT TO ESTABLISH ASSAY EVALUATION STRATEGY | National Institutes Of Health | 541618 | $529K | Feb 6, 2023 | Aug 31, 2026 |
| 75N95024P00608 ↗ | OPTION PERIOD 1: OSA MENTORSHIP SUPPORT SERVICES | National Institutes Of Health | 611430 | $47K | Sep 20, 2024 | Sep 19, 2026 |
| 75N92025F00001 ↗ | RADX INNOVATION FUNNEL FOR HEALTH TECHNOLOGIES - AWARD MANAGEMENT, TASK ORDER 005 | National Institutes Of Health | 541618 | $1.5M | Sep 29, 2025 | Sep 28, 2026 |
| 75N92024F00004 ↗ | RADX INNOVATION FUNNEL FOR HEALTH TECHNOLOGIES - COMMERCIALIZATION CENTER | National Institutes Of Health | 541618 | $3.6M | Sep 30, 2024 | Sep 29, 2026 |
| 75N92024F00001 ↗ | RADX INNOVATION FUNNEL FOR HIV DIAGNOSTICS - COMMERCIALIZATION CENTER | National Institutes Of Health | 541618 | $2.8M | May 28, 2024 | Jun 30, 2027 |
| 75N92025F00001 ↗ | RAPID ACCELERATION OF DIAGNOSTICS AWARD MANAGEMENT - HIV WP2 AWARDS | National Institutes Of Health | 541618 | $6.4M | Sep 26, 2025 | Sep 25, 2027 |
Largest awards
| PIID | Description | Agency | NAICS | Obligated | Start | End |
|---|---|---|---|---|---|---|
| 75N92025F00001 ↗ | RAPID ACCELERATION OF DIAGNOSTICS AWARD MANAGEMENT - HIV WP2 AWARDS | National Institutes Of Health | 541618 | $6.4M | Sep 26, 2025 | Sep 25, 2027 |
| 75N92025F00002 ↗ | NIBIB INNOVATION FUNNEL COMMERCIALIZATION CENTER - RADX BLUEPRINT MEDTECH TRANSLATOR COHORT 3 | National Institutes Of Health | 541618 | $5.4M | Aug 29, 2025 | Aug 28, 2026 |
| 75N92024F00004 ↗ | RADX INNOVATION FUNNEL FOR HEALTH TECHNOLOGIES - COMMERCIALIZATION CENTER | National Institutes Of Health | 541618 | $3.6M | Sep 30, 2024 | Sep 29, 2026 |
| 75N92024F00001 ↗ | RADX INNOVATION FUNNEL FOR HIV DIAGNOSTICS - COMMERCIALIZATION CENTER | National Institutes Of Health | 541618 | $2.8M | May 28, 2024 | Jun 30, 2027 |
| 75N92025F00001 ↗ | RADX INNOVATION FUNNEL FOR HEALTH TECHNOLOGIES - AWARD MANAGEMENT, TASK ORDER 005 | National Institutes Of Health | 541618 | $1.5M | Sep 29, 2025 | Sep 28, 2026 |
| 75N92025F00001 ↗ | RADX BLUEPRINT MEDTECH TRANSLATOR COHORT 2 - COMMERCIALIZATION CENTER | National Institutes Of Health | 541618 | $1.0M | Jun 2, 2025 | Jun 1, 2026 |
| 75N92023F00003 ↗ | RADX INDEPENDENT TEST ASSESSMENT PROGRAM FOR MPOX LESION PANEL - COMMERCIALIZATION CENTER | National Institutes Of Health | 541618 | $750K | Sep 27, 2023 | Dec 31, 2025 |
| 75N92023F00001 ↗ | COMMERCIALIZATION CENTER TASK ORDER FOR CANCER SCREENING RESEARCH NETWORK - CONSULTANT TO ESTABLISH ASSAY EVALUATION STRATEGY | National Institutes Of Health | 541618 | $529K | Feb 6, 2023 | Aug 31, 2026 |
| HR001125C0049 ↗ | SWITCH PROGRAM (ICCG) BASE | Defense Advanced Research Projects Agency | 541714 | $385K | Jan 24, 2025 | Jan 23, 2028 |
| 75N92023P00086 ↗ | DEBUT CHALLENGE MANAGEMENT CONTRACT | National Institutes Of Health | 541611 | $265K | Mar 17, 2023 | Mar 16, 2026 |
| 75N95024P00608 ↗ | OPTION PERIOD 1: OSA MENTORSHIP SUPPORT SERVICES | National Institutes Of Health | 611430 | $47K | Sep 20, 2024 | Sep 19, 2026 |
| 75N94024P00690 ↗ | EOI::ENDING RADICAL AND WASTEFUL GOVERNMENT DEI PROGRAMS AND PREFERENCING (JANUARY 20, 2025)::EOI TERMINATION FOR CONVENIENCE OF THE GOVERNMENT | National Institutes Of Health | 541611 | $0 | Sep 13, 2024 | Sep 12, 2025 |
| 75N92021F00002 ↗ | THE PURPOSE OF THIS MODIFICATION IS TO CANCEL CLIN 3 IN ITS ENTIRETY. | National Institutes Of Health | 541990 | $0 | Mar 5, 2021 | Jul 15, 2021 |
| 75N92023F00004 ↗ | RAPID ACCELERATION OF DIAGNOSTICS (RADX) CLINICAL EVALUATION SERVICES -TASK ORDER 06 | National Institutes Of Health | 541990 | $0 | Jun 1, 2023 | Mar 31, 2026 |
| 75N92022D00013 ↗ | NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING (NIBIB) INNOVATION FUNNEL COMMERCIALIZATION CENTER | National Institutes Of Health | 541618 | $0 | Sep 1, 2022 | — |
| 75N92023F00002 ↗ | INNOVATION FUNNEL FOR COVID19 - COMMERCIALIZATION CENTER | National Institutes Of Health | 541618 | $0 | Mar 15, 2023 | Jun 30, 2026 |
| 75N92024F00002 ↗ | RADX INNOVATION FUNNEL FOR ENDOMETRIOSIS DIAGNOSTICS - COMMERCIALIZATION CENTER | National Institutes Of Health | 541618 | $0 | Jul 15, 2024 | Mar 14, 2026 |
| 75N92024F00003 ↗ | RADX BLUEPRINT MEDTECH TRANSLATOR COHORT 1 - COMMERCIALIZATION CENTER | National Institutes Of Health | 541618 | $0 | Jul 17, 2024 | Dec 31, 2025 |
| 75N92023D00001 ↗ | NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING (NIBIB) INNOVATION FUNNEL AWARD MANAGEMENT | National Institutes Of Health | 541618 | $0 | Feb 1, 2023 | — |
| 75N92023D00007 ↗ | NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING (NIBIB) RAPID ACCELERATION OF DIAGNOSTICS AWARD MANAGEMENT | National Institutes Of Health | 541618 | $0 | Jun 1, 2023 | — |
| 75N92024F00001 ↗ | RADX INNOVATION FUNNEL FOR HIV DIAGNOSTICS - AWARD MANAGEMENT | National Institutes Of Health | 541618 | $0 | Jun 7, 2024 | Jun 30, 2026 |
| 75N92023F00003 ↗ | RADX INNOVATION FUNNEL FOR COVID-19 - AWARD MANAGEMENT | National Institutes Of Health | 541618 | $0 | Jun 1, 2023 | May 31, 2026 |
| 75N92022F00002 ↗ | NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING (NIBIB) INNOVATION FUNNEL FOR HIV/AIDS - COMMERCIALIZATION CENTER | National Institutes Of Health | 541618 | $0 | Sep 1, 2022 | Sep 30, 2024 |
| 75N92022F00003 ↗ | RADX INDEPENDENT TEST ASSESSMENT PROGRAM FOR MONKEYPOX - COMMERCIALIZATION CENTER | National Institutes Of Health | 541618 | $0 | Sep 14, 2022 | Jun 30, 2025 |
| 75N92023F00002 ↗ | NIBIB - RAPID ACCELERATION OF DIAGNOSTICS (RADX) CLINICAL EVALUATION SERVICES. TASK ORDER 04 - RADX PROJECTS 6818 AND 13379 | National Institutes Of Health | 541990 | $-0 | Dec 29, 2022 | May 31, 2024 |